{"id":205,"date":"2020-05-29T11:59:58","date_gmt":"2020-05-29T02:59:58","guid":{"rendered":"https:\/\/gucvmed.med.gunma-u.ac.jp\/0_web\/?page_id=205"},"modified":"2020-05-29T11:59:58","modified_gmt":"2020-05-29T02:59:58","slug":"2016%e5%b9%b4%e7%a0%94%e7%a9%b6%e4%bc%9a%e3%83%bb%e8%ac%9b%e6%bc%94%e4%bc%9a","status":"publish","type":"page","link":"https:\/\/gucvmed.med.gunma-u.ac.jp\/?page_id=205","title":{"rendered":"2016\u5e74\u7814\u7a76\u4f1a\u30fb\u8b1b\u6f14\u4f1a"},"content":{"rendered":"<section>\n<h4>\u7b2c28\u56de\u3000\u81e8\u5e8a\u4e0d\u6574\u8108\u7814\u7a76\u4f1a\u30002016.1.9\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u98ef\u585a\u8cb4\u58eb\u3001\u98ef\u5cf6\u8cb4\u53f2\u3001\u592a\u7530\u660c\u6a39\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u91d1\u53e4\u5584\u660e\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5fc3\u5ba4\u7d30\u52d5\u8607\u751f\u5f8c\u306eBrugada\u75c7\u5019\u7fa4\u306b\u51a0\u6523\u7e2e\u6027\u72ed\u5fc3\u75c7\u306e\u4f75\u767a\u304c\u7591\u308f\u308c\u305f1\u4f8b\uff0e<\/p>\n<\/section>\n<section>\n<h4>\u5faa\u74b0\u5668\u8a3a\u7642\u304b\u3089\u307f\u305f\u7cd6\u5c3f\u75c5\u6cbb\u7642\u3092\u8003\u3048\u308b\u4f1ain\u7fa4\u99ac\u30002016.1.15(\u524d\u6a4b)<\/h4>\n<p>1)\t\u798f\u7530\u5ef6\u662d<br \/>\nDM\u5408\u4f75\u306e\u5faa\u74b0\u5668\u75be\u60a3\u60a3\u8005\u306b\u5bfe\u3059\u308bSGLT2\u963b\u5bb3\u85ac\u306e\u4f7f\u7528\u7d4c\u9a13<\/p>\n<p>2)\t\u6e05\u6c34\u7f8e\u6d25\u592b<br \/>\n\u9ad8\u8840\u7cd6\u3068\u5408\u4f75\u75c7\u306e\u7ba1\u7406\u306e\u554f\u984c\u70b9<\/p>\n<\/section>\n<section>\n<h4>\u7fa4\u99acCKD\u5fc3\u7b4bSPECT\u691c\u8a0e\u4f1a\u30002016.1.19\uff08\u524d\u6a4b\uff09<\/h4>\n<p>1) \u4f50\u85e4\u4e07\u57fa\u4eba<br \/>\n\u7fa4\u99acCKD\u30b5\u30d6\u89e3\u6790\u5831\u544a\uff5e\u5b89\u9759\u6642\u306eDyssynchrony\u306f\u8ca0\u8377MPI\u306e\u7570\u5e38\u3092\u691c\u51fa\u3057\u5f97\u308b\u304b\uff1f\uff5e<\/p>\n<p>2)\u7b20\u9593\u3000\u5468<br \/>\n\u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d71\u5e74\u5f8c\u306e\u30c7\u30fc\u30bf\u89e3\u6790\u7d50\u679c\u5831\u544a\uff5eEuropean Journal of Nuclear Medicine and Molecular Imaging\u63b2\u8f09\u7d50\u679c\u5185\u5bb9\u3092\u4e2d\u5fc3\u306b\uff5e<\/p>\n<p>3)\t\u5916\u5c71\u5353\u4e8c<br \/>\n\u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d7\u6700\u7d42\u89e3\u6790\u7d50\u679c\u5831\u544a\uff5eCKD\u60a3\u8005\u306e\u4e88\u5f8c\u8a55\u4fa1\u306b\u304a\u3051\u308b\u5fc3\u7b4b\u8840\u6d41SPECT\u306e\u6709\u7528\u6027\uff5e<\/p>\n<\/section>\n<section>\n<h4>\u7b2c15\u56de\u5317\u95a2\u6771\u5fc3\u8840\u7ba1\u5185\u5206\u6cccResearch Meeting\u30002016.1.22\uff08\u6771\u4eac\uff09<\/h4>\n<p>1\uff09\u30b3\u30e1\u30f3\u30c6\u30fc\u30bf\u30fc\u3000\u5009\u6797\u6b63\u5f66<br \/>\n\u65e5\u672c\u4eba\u3067\u793a\u3055\u308c\u305f\u30e1\u30d0\u30ed\u30c1\u30f3\u306e\u512a\u308c\u305f\u6709\u7528\u6027\uff08\u6700\u65b0\u306e\u77e5\u898b\uff09<\/p>\n<p>2\uff09\u9808\u6c38\u6d69\u7ae0\u3001\u677e\u4e95\u5f18\u6a39\u3001\u78ef\u3000\u9054\u4e5f\u3001\u677e\u5742\u3000\u8ce2\u3001\u5cf6\u91ce\u3000\u4ec1\u3001\u6a2a\u5c71\u77e5\u884c\u3001\u5009\u6797\u6b63\u5f66<br \/>\nAMPK-KLF4\u7d4c\u8def\u306e\u6d3b\u6027\u5316\u304c\u8840\u7ba1\u5e73\u6ed1\u7b4b\u7d30\u80de\u306e\u5f62\u8cea\u8ee2\u63db\u3068\u5897\u6b96\u306b\u53ca\u307c\u3059\u5f71\u97ff<\/p>\n<\/section>\n<section>\n<h4>30\u56de\u8d64\u57ce\u5faa\u74b0\u5668\u30d5\u30a9\u30fc\u30e9\u30e0\u30002016.1.29(\u524d\u6a4b)<\/h4>\n<p>\u7b20\u9593\u3000\u5468<br \/>\n\u5faa\u74b0\u5668\u75be\u60a3\u306b\u304a\u3051\u308b\u5fc3\u81d3\u4ea4\u611f\u795e\u7d4c\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306e\u6709\u7528\u6027<\/p>\n<\/section>\n<section>\n<h4>\u7b2c2\u56deCMR GUNMA\uff08\u7fa4\u99ac\u5fc3\u81d3MRI\u7814\u7a76\u4f1a\uff092016.2.9\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u5927\u5c71\u5584\u662d<br \/>\nCMR\u306b\u3088\u308bAortic Stiffness\u306e\u8a55\u4fa1<\/p>\n<\/section>\n<section>\n<h4>CVN.XAR.\u897f\u591a\u6469\u533b\u5e2b\u4f1a\u8b1b\u6f14\u4f1a2016.2.10\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nSingle Drug Approach: \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>\u65e5\u672c\u533b\u5e2b\u4f1a\u751f\u6daf\u6559\u80b2\u8b1b\u5ea7\u30002016.2.12\uff08\u91e7\u8def\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u7cd6\u5c3f\u75c5\u306b\u5408\u4f75\u3059\u308b\u52d5\u8108\u786c\u5316\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u3068\u6cbb\u7642\u6226\u7565<\/p>\n<\/section>\n<section>\n<h4>\u7b2c\uff16\u56deBasic and Clinical PH Conference\u30002016.2.13\uff08\u5927\u962a\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\n\u30da\u30ea\u30aa\u30b9\u30c1\u30f3\u767a\u73fe\u7d30\u80de\u3067\u306eTGF\u03b2\u30b7\u30b0\u30ca\u30eb\u963b\u5bb3\u306f\u80ba\u9ad8\u8840\u5727\u306e\u9032\u5c55\u3092\u6291\u5236\u3059\u308b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c29\u56deEducational Seminar in Cardiology 2016.2.16\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u7cd6\u5c3f\u75c5\u306b\u5408\u4f75\u3059\u308b\u52d5\u8108\u786c\u5316\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u3068\u4e88\u9632\u6226\u7565<\/p>\n<\/section>\n<section>\n<h4>\u7b2c3\u56de\u7fa4\u99ac\u770c\u6297\u51dd\u56fa\u7642\u6cd5\u5f8c\u63f4\u4f1a\u30002016.2.17(\u524d\u6a4b)<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\n\u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>COPD\u6cbb\u7642\u30bb\u30df\u30ca\u30fc\uff5e\u5168\u4eba\u7684COPD\u6cbb\u7642\uff5e2016.2.19(\u9ad8\u5d0e)<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\n\u5faa\u74b0\u5668\u5185\u79d1\u533b\u304b\u3089\u8a3a\u308bCOPD\u6cbb\u7642\u85ac<\/p>\n<\/section>\n<section>\n<h4>\u7b2c\uff11\uff15\u56de\u7fa4\u99ac\u81e8\u5e8a\u30ab\u30f3\u30d5\u30a1\u30e9\u30f3\u30b9\u30002016.2.19\uff08\u524d\u6a4b\uff09<\/h4>\n<p>1\uff09\u6751\u7530\u8aa0<br \/>\n\u9f20\u5f84\u30d8\u30eb\u30cb\u30a2\u8853\u5f8c\u306b\u5408\u4f75\u3057\u305f\u51a0\u6523\u7e2e\u6027\u72ed\u5fc3\u75c7\u306e\u4e00\u4f8b<\/p>\n<p>\uff12\uff09\u5e02\u5ddd\u5553\u4ecb<br \/>\n\u5de6\u5ba4\u5c40\u6240\u74a7\u904b\u52d5\u7570\u5e38\u3092\u793a\u3057\u305f\u75c7\u4f8b\u306e\u691c\u8a0e<\/p>\n<p>\uff13\uff09\u5916\u5c71\u5353\u4e8c<br \/>\n\u51a0\u6523\u7e2e\u6027\u72ed\u5fc3\u75c7\u306e\u4fdd\u5b58\u7684\u6cbb\u7642\u306b\u52a0\u3048\u30b9\u30c8\u30ed\u30f3\u30b0\u30b9\u30bf\u30c1\u30f3\u306e\u8ffd\u52a0\u6295\u4e0e\u306e\u6709\u7528\u6027\u2015\u5fc3\u81d3\u4ea4\u611f\u795e\u7d4c\u6d3b\u6027\u3068\u5185\u76ae\u6a5f\u80fd\u3078\u304a\u3088\u307c\u3059\u52b9\u679c\u2015<\/p>\n<p>\uff14\uff09\u6885\u5c71\u6566<br \/>\n\u51a0\u6523\u7e2e\u72ed\u5fc3\u75c7\u3067follow\u4e2d\u306bACS\u3092\u767a\u75c7\u3057\u3001\u7dca\u6025\u3067PCI\u3092\u65bd\u884c\u3057\u305f\u75c7\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u30a4\u30b0\u30b6\u30ec\u30eb\u30c8PE\/DVT\u9069\u5fdc\u8ffd\u52a0\u8a18\u5ff5\u8b1b\u6f14\u4f1a2016.2.23\uff08\u5927\u5206\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nSingle Drug Approach: \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>\u7b2c19\u56de\u5927\u962a\uff15\u5927\u5b66\u5408\u540c\u5fc3\u81d3\u30bb\u30df\u30ca\u30fc\u30002016.2.26(\u5927\u962a)<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u7cd6\u5c3f\u75c5\u306b\u5408\u4f75\u3059\u308b\u52d5\u8108\u786c\u5316\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u3068\u4e88\u9632\u6226\u7565<\/p>\n<\/section>\n<section>\n<h4>\u03b21-blocker Innovation Conference in Gunma 2016 2016.3.4(\u524d\u6a4b)<\/h4>\n<p>1\uff09\t\u5317\u689d\u7fa9\u660e<br \/>\n\u81bf\u80f8\u3092\u4f34\u3046Af\u306b\u5bfe\u3057\u3066\u30e9\u30f3\u30b8\u30aa\u30ed\u30fc\u30eb\u3092\u4f7f\u7528\u3057\u305f1\u4f8b<\/p>\n<p>2\uff09\t\u5929\u91ce\u6676\u592b<br \/>\n\u86f8\u58fa\u578b\u5fc3\u7b4b\u75c7\u3092\u5408\u4f75\u3057\u305f\u7532\u72b6\u817a\u30af\u30ea\u30fc\u30bc\u306b\u5bfe\u3057\u30e9\u30f3\u30b8\u30aa\u30ed\u30fc\u30eb\u3092\u4f7f\u7528\u3057\u305f1\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c10\u56deCardio-Diabetes\u7814\u7a76\u4f1a\u30002016.3.5-6(\u6771\u4eac)<\/h4>\n<p>\u78ef\u3000\u9054\u4e5f<br \/>\nDeletion of fatty acid binding protein-4 and -5 exacerbates cardiac dysfunction because of insufficient ATP production during pressure overload in mice<\/p>\n<\/section>\n<section>\n<h4>CV\uff06Diabetes Forum in Gunma\u30002016.3.7(\u524d\u6a4b)<\/h4>\n<p>\u5929\u91ce\u660c\u592b\u30fb\u9577\u6cbc\u6587\u96c4<br \/>\n\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3<br \/>\n\u7cd6\u5c3f\u75c5\u6cbb\u7642\u7d04\u306e\u6700\u9069\u306a\u9078\u629e\u306b\u3064\u3044\u3066<\/p>\n<\/section>\n<section>\n<h4>\u7b2c2\u56deG-VTE\u7814\u7a76\u4f1a\uff5e\u30a4\u30b0\u30b6\u30ec\u30eb\u30c8\u9320 \u9069\u5fdc\u8ffd\u52a0\u8a18\u5ff5\u8b1b\u6f14\u4f1a\uff5e2016.3.8\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\nSingle Drug Approach\u306e\u53ef\u80fd\u6027<\/p>\n<\/section>\n<section>\n<h4>\u591a\u8077\u7a2e\u3067\u307f\u308b\u5728\u5b85\u533b\u7642\u7814\u4fee\u4f1a\uff5e\u524d\u6a4b\u5e02\u533b\u5e2b\u4f1a\u300c\u307e\u3048\u3070\u3057\u5728\u5b85\u533b\u7642\u587e\u300d\u7814\u4fee\u4f1a\uff5e2016.3.19(\u524d\u6a4b) <\/h4>\n<p>\u5c71\u6d1e\u5584\u6052<br \/>\n\u5728\u5b85\u4eba\u5de5\u547c\u5438\u5668\u7642\u6cd5\u306b\u3064\u3044\u3066<\/p>\n<\/section>\n<section>\n<h4>\u7b2c2\u56de\u7fa4\u99ac\u5185\u79d1\u6551\u6025\u6cbb\u7642\u7814\u7a76\u4f1a\u3010G-MECC\u3011\u30002016.3.22\u3000(\u524d\u6a4b)<\/h4>\n<p>\u4f50\u85e4\u4e07\u57fa\u4eba<br \/>\n\u8840\u6813\u75c7\u306e\u6cbb\u7642\u306b\u3064\u3044\u3066<\/p>\n<\/section>\n<section>\n<h4>\u7b2c14\u56deGunma Cardiovascular Catheter Therapeutics and Trialist Group(G-CCT)2016.4.9(\u524d\u6a4b)<\/h4>\n<p>1)\t\u6238\u7530\u548c\u8fb0<br \/>\n\u5faa\u74b0\u5668\u5185\u79d1\u533b\u304b\u3089\u307f\u305f\u30d3\u30b0\u30a2\u30ca\u30a4\u30c9\u85ac<\/p>\n<p>2)\t\u4f50\u85e4\u4e07\u57fa\u4eba<br \/>\n\u75c7\u4f8b\u691c\u8a0e<\/p>\n<p>3)\t\u7530\u53e3\u54f2\u4e5f<br \/>\n\u75c7\u4f8b\u691c\u8a0e<\/p>\n<\/section>\n<section>\n<h4>\u5742\u6771\u5e38\u7dcf\u533b\u7642\u9023\u643a\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b92016.4.12\uff08\u8328\u57ce\u30fb\u5742\u6771\u5e02\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nSingle Drug Approach: \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>\u6df1\u8c37\u8d64\u5341\u5b57\u5730\u57df\u9023\u643a\u8b1b\u6f14\u4f1a\u30002016.4.26\uff08\u6df1\u8c37\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nSingle Drug Approach: \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>\u7b2c17\u56de\u7fa4\u99ac\u751f\u6d3b\u7fd2\u6163\u75c5\u30d5\u30a9\u30fc\u30e9\u30e0\u30002016.4.26(\u524d\u6a4b)<\/h4>\n<p>\u6751\u7530\u8aa0<br \/>\n\u7d4c\u76ae\u7684\u5927\u52d5\u8108\u5f01\u7f6e\u63db\u8853\uff08TAVR\uff09\u5f8c\u306e\u904b\u52d5\u8010\u7528\u80fd\u306b\u3064\u3044\u3066<\/p>\n<\/section>\n<section>\n<h4>\u7b2c26\u56de\u3000Echo-G\u30002016.5.6 (\u524d\u6a4b)<\/h4>\n<p>\u5ca1\u7530\u9855\u4e5f\u3001\u9ed2\u6ca2\u5e78\u55e3<br \/>\n\u30df\u30cb\u30ec\u30af\u30c1\u30e3\u30fc\u3000\u5fc3\u81d3\u8d85\u97f3\u6ce2\u691c\u67fb\u306e\u6a19\u6e96\u5316\u3000\u3000\u7fa4\u99ac\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u306e\u5fc3Echo\u5ba4\u306e\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u8133\u5fc3\u8840\u7ba1\u30b1\u30a2\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u30002016.5.9(\u6c34\u6238)<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u7cd6\u5c3f\u75c5\u60a3\u8005\u306e\u5faa\u74b0\u5668\u75be\u60a3\u4e88\u9632\u306e\u305f\u3081\u306e\u30ea\u30b9\u30af\u7ba1\u7406\u306e\u3042\u308a\u65b9\uff1a\u6700\u65b0\u306e\u8a71\u984c\u3092\u8e0f\u307e\u3048\u3066<\/p>\n<\/section>\n<section>\n<h4>\u7b2c\u4e00\u56de\u897f\u90e8\u652f\u90e8\u7814\u4fee\u4f1a2016.5.12\uff08\u8239\u6a4b\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nSingle Drug Approach: \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>\u7b2c9\u56de\u7fa4\u99ac\u5fc3\u4e0d\u5168\u3068Vasopressin\u8b1b\u6f14\u4f1a\u30002016.5.13(\u524d\u6a4b)<\/h4>\n<p>1)\t\u5f8c\u85e4\u6176\u5927<br \/>\n\u5165\u9662\u5916\u6765\u60a3\u8005\u3078\u306e\u30c8\u30eb\u30d0\u30d7\u30bf\u30f3\u306e\u4f7f\u7528\u7d4c\u9a13\u304b\u3089\u306e\u8003\u5bdf<\/p>\n<p>2)\t\u9577\u5742\u5d07\u53f8<br \/>\nCKD\u3092\u4f34\u3046\u5fc3\u4e0d\u5168\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30c8\u30eb\u30d0\u30d7\u30bf\u30f3\u65e9\u671f\u5c0e\u5165\u306e\u89e3\u6790<\/p>\n<\/section>\n<section>\n<h4>\u7b2c28\u56de\u4e21\u6bdb\u4e0d\u6574\u8108\u30bb\u30df\u30ca\u30fc\u30002016.5.14(\u5b87\u90fd\u5bae)<\/h4>\n<p>\u98ef\u585a\u8cb4\u58eb\u3001\u91d1\u53e4\u5584\u660e\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u5165\u6c5f\u5fe0\u4fe1\u3001\u592a\u7530\u660c\u6a39\u3001\u98ef\u5cf6\u8cb4\u53f2\u3001\u7530\u6751\u672a\u592e\u3001\u7530\u6751\u5cfb\u592a\u90ce\u3001\u9f4b\u85e4\u7ae0\u5b8f\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u983b\u62cd\u6642\u306e\u307f\u9855\u6027\u5316\u3059\u308bnodoventricular fiber\u3092\u4f34\u3046slow-slow \u623f\u5ba4\u7d50\u7bc0\u30ea\u30a8\u30f3\u30c8\u30ea\u30fc\u6027\u983b\u62cd\u306e\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c33\u56de\u65e5\u672c\u6838\u533b\u5b66\u6280\u8853\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u7dcf\u4f1a\u3000\u7fa4\u99ac2016.5.14-15\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u7b20\u9593\u3000\u5468<br \/>\n\u6838\u533b\u5b66\u306b\u304a\u3051\u308b\u753b\u50cf\u8a3a\u65ad\uff08\u5faa\u74b0\u5668\u9818\u57df\uff09\uff5e\u5c02\u9580\u533b\u306f\u3053\u3053\u3092\u8a3a\u308b\uff5e<\/p>\n<\/section>\n<section>\n<h4>Deabetes and CVD conference IN SAITAMA 2016.5.16(\u3055\u3044\u305f\u307e)<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u7cd6\u5c3f\u75c5\u60a3\u8005\u306e\u5faa\u74b0\u5668\u75be\u60a3\u4e88\u9632\u306e\u305f\u3081\u306e\u30ea\u30b9\u30af\u7ba1\u7406\u306e\u3042\u308a\u65b9\uff1a\u6700\u65b0\u306e\u8a71\u984c\u3092\u8e0f\u307e\u3048\u3066<\/p>\n<\/section>\n<section>\n<h4>Boehringer Ingelheim Lung Cancer Conference 2016 in Gunma\u30002016.5.19(\u524d\u6a4b) <\/h4>\n<p>\u6e05\u6c34\u96c4\u81f3\u3000<br \/>\nEGFR\u70b9\u5909\u7570\u967d\u6027\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308bafatinib\u306e\u4f7f\u7528\u7d4c\u9a13\n <\/p>\n<\/section>\n<section>\n<h4>\u7b2c10\u56de\u304a\u8336\u306e\u6c34\u30cf\u30fc\u30c8\u30ea\u30ba\u30e0\u7814\u7a76\u4f1a\u30002016.5.21(\u6771\u4eac)<\/h4>\n<p>\u91d1\u53e4\u5584\u660e<br \/>\nsuperior slow pathway\u3068\u65b0\u3057\u3044\u623f\u5ba4\u7d50\u7bc0\u30ea\u30a8\u30f3\u30c8\u30ea\u30fc\u6027\u983b\u62cd\u306e\u63d0\u5531\uff0e <\/p>\n<\/section>\n<section>\n<h4>\u770c\u5317\u8840\u6813\u585e\u6813\u75c7\u7814\u7a76\u4f1a\u30002016.5.24\uff08\u8328\u57ce\u30fb\u65e5\u7acb\u5e02\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nSingle Drug Approach: \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>Cardiovascular Risk Manegement Forum 2016 2016.5.24(\u524d\u6a4b)<\/h4>\n<p>1)\t\u5965\u91ce\u3000\u8302<br \/>\n\u7cd6\u5c3f\u75c5\u8a3a\u7642\u306e\u65e5\u5e38<\/p>\n<p>2)\t\u7b20\u9593\u3000\u5468<br \/>\n\u5fc3\u4e0d\u5168\u6cbb\u7642\u3092\u518d\u8003\u3059\u308b\uff5eSGLT2\u963b\u5bb3\u5264\u304c\u3082\u305f\u3089\u3059\u5f71\u97ff\u3092\u542b\u3081\u3066\uff5e<\/p>\n<\/section>\n<section>\n<h4>\u6803\u6728\u770c\u7cd6\u5c3f\u75c5\u81e8\u5e8a\u7814\u7a76\u4f1a2016\u30002016.5.26(\u5b87\u90fd\u5bae)<\/h4>\n<p>\u7b20\u9593\u3000\u5468<br \/>\n\u5fc3\u4e0d\u5168\u6cbb\u7642\u3092\u518d\u8003\u3059\u308b\uff5eSGLT2\u963b\u5bb3\u5264\u304c\u3082\u305f\u3089\u3059\u5f71\u97ff\u3092\u542b\u3081\u3066\uff5e<\/p>\n<\/section>\n<section>\n<h4>\u80ba\u304c\u3093\u816b\u760d\u514d\u75ab\u30bb\u30df\u30ca\u30fc in \u7fa4\u99ac\u30002016.5.27(\u524d\u6a4b)<\/h4>\n<p>\u6e05\u6c34\u96c4\u81f3\u3000<br \/>\nNSCLC\u306b\u5bfe\u3059\u308b\u30cb\u30dc\u30eb\u30de\u30d6\u306e\u4f7f\u7528\u7d4c\u9a13<\/p>\n<\/section>\n<section>\n<h4>\u7b2c\uff14\uff16\u56de\u81e8\u5e8a\u5fc3\u81d3\u96fb\u6c17\u751f\u7406\u7814\u7a76\u4f1a\u30002016.5.28\uff08\u91d1\u6ca2\uff09<\/h4>\n<p>\u98ef\u585a\u8cb4\u58eb\u3001\u91d1\u53e4\u5584\u660e\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u5165\u6c5f\u5fe0\u4fe1\u3001\u592a\u7530\u660c\u6a39\u3001\u98ef\u5cf6\u8cb4\u53f2\u3001\u7530\u6751\u672a\u592e\u3001\u7530\u6751\u5cfb\u592a\u90ce\u3001\u9f4b\u85e4\u7ae0\u5b8f\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u983b\u62cd\u6642\u306e\u307f\u9855\u6027\u5316\u3059\u308bnodoventricular fiber\u3092\u4f34\u3046slow-slow \u623f\u5ba4\u7d50\u7bc0\u30ea\u30a8\u30f3\u30c8\u30ea\u30fc\u6027\u983b\u62cd\u306e\u4e00\u4f8b\uff0e<\/p>\n<\/section>\n<section>\n<h4>Research PlaNet2016 2016.5.28-29(\u6771\u4eac)<\/h4>\n<p>Yogi Umbarawan<br \/>\nDeletion of Fatty Acid Binding Protein-4 and -5 Exacerbate Cardiac Dysfunction Because of Insufficient ATP oroduction during Pressure Overload in Mice.<\/p>\n<\/section>\n<section>\n<h4>\u7b2c48\u56de\u57fc\u7389\u4e0d\u6574\u8108\u30da\u30fc\u30b7\u30f3\u30b0\u7814\u7a76\u4f1a\u30002016.6.4(\u3055\u3044\u305f\u307e)<\/h4>\n<p>\u91d1\u53e4\u5584\u660e\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u5165\u6c5f\u5fe0\u4fe1\u3001\u98ef\u585a\u8cb4\u58eb\u3001\u7530\u6751\u5cfb\u592a\u90de\u3001\u7530\u6751\u7f8e\u592e\u3001\u9f4b\u85e4\u7ae0\u5b8f\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u53f3\u623f\u524d\u5074\u58c1\u307e\u3067\u9032\u5c55\u3059\u308bsuperior slow pathway\u3092\u4ecb\u3059\u308bfast-slow\u623f\u5ba4\u7d50\u7bc0\u30ea\u30a8\u30f3\u30c8\u30ea\u30fc\u6027\u983b\u62cd\u306e\u4e00\u4f8b\uff0e <\/p>\n<\/section>\n<section>\n<h4>\u7b2c36\u56de\u65e5\u672c\u30db\u30eb\u30bf\u2015\u30fb\u30ce\u30f3\u30a4\u30f3\u30d9\u30a4\u30b7\u30d6\u5fc3\u96fb\u5b66\u7814\u7a76\u4f1a\u30002016.6.11(\u5927\u5bae)<\/h4>\n<p>\u7530\u6751\u5cfb\u592a\u90ce\u3001\u91d1\u53e4\u5584\u660e\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u5165\u6c5f\u5fe0\u4fe1\u3001\u592a\u7530\u660c\u6a39\u3001\u7530\u6751\u672a\u592e\u3001\u98ef\u585a\u8cb4\u58eb\u3001\u9f4b\u85e4\u7ae0\u5b8f\u3001\u5009\u6797\u6b63\u5f66\u3001\u4e39\u4e0b\u6b63\u4e00\u3001\u5ca9\u5d0e\u4fca\u54c9\u3001\u91d1\u5b50\u514b\u5df1\u3001\u5e83\u4e95\u77e5\u6b73\u3001\u95a2\u53e3\u3000\u8aa0<br \/>\n\u9673\u65e7\u6027\u5fc3\u7b4b\u6897\u585e\u4f8b\u306eJ\u6ce2\u306e\u6210\u56e0\u3068\u4e88\u5f8c\u3068\u306e\u95a2\u9023 -\u767a\u75c7\u524d\u5f8c\u306eJ\u6ce2\u306e\u5909\u5316\u304b\u3089\u306e\u691c\u8a0e-\uff0e <\/p>\n<\/section>\n<section>\n<h4>Thrombosis Conference in Shiga\u30002016.6.16 (\u6ecb\u8cc0)<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nSingle Drug Approach: \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>\uff27 \uff27\uff29\uff32\uff2c\uff33\u30002016.6.17(\u524d\u6a4b)<\/h4>\n<p>\u4f50\u85e4\u6d69\u5b50<br \/>\n\u5faa\u74b0\u5668\u8a3a\u7642\u306b\u304a\u3051\u308b\u4e3b\u8981\u75c7\u5019\u3068\u6f22\u65b9<\/p>\n<\/section>\n<section>\n<h4>\u7b2c2\u56de\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u56f3\u7814\u7a76\u4f1a\u30002016.6.18(\u6771\u4eac)<\/h4>\n<p>\u9ed2\u6ca2\u5e78\u55e3\u3001\u5ca1\u7530\u9855\u4e5f\u3001\u5c0f\u4fdd\u65b9\u3000\u512a\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u5409\u7530\u304f\u306b\u5b50\u3001\u6238\u7530\u548c\u8fb0\u3001\u677e\u5c3e\u5f25\u679d\u3001\u9ad8\u9593\u5178\u660e\u3001\u6751\u4e0a\u6b63\u5df3\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u52b4\u4f5c\u6642\u606f\u5207\u308c\u306e\u539f\u56e0\u7cbe\u67fb\u306b\u904b\u52d5\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u56f3\u691c\u67fb\u304c\u6709\u7528\u3067\u3042\u3063\u305f\u4e21\u5c16\u9038\u8131\u306b\u3088\u308b\u4e2d\u7b49\u5ea6MR\u3092\u4f34\u3046MCTD\u306e\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u5c71\u68a8\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u3000\u533b\u7642\u9023\u643a\u306e\u4f1a\u30002016.6.29 (\u7532\u5e9c)<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nSingle Drug Approach: \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>\u7b2c\uff12\u56deKUMAMOTO Heart Rhythm Summit2016.7.1\uff08\u718a\u672c\uff09<\/h4>\n<p>\u91d1\u53e4\u5584\u660e<br \/>\nsuperior slow pathway\u3068\u65b0\u3057\u3044\u623f\u5ba4\u7d50\u7bc0\u30ea\u30a8\u30f3\u30c8\u30ea\u30fc\u6027\u983b\u62cd\u306e\u63d0\u5531\uff0e<\/p>\n<\/section>\n<section>\n<h4>\u7b2c1\u56de\u3000\u5317\u95a2\u6771\u5faa\u74b0\u5668\u75c5\u9662\u30fb\u6e0b\u5ddd\u5730\u533a\u533b\u5e2b\u4f1a\u30e1\u30c7\u30a3\u30ab\u30eb\u30bb\u30df\u30ca\u30fc2016.7.7(\u6e0b\u5ddd)<\/h4>\n<p>\u5317\u689d\u7fa9\u660e<br \/>\n\u9589\u585e\u6027\u52d5\u8108\u786c\u5316\u75c7\u306b\u304a\u3051\u308b\u5fc3\u81d3\u5f01\u819c\u75c7\u3068\u30ea\u30dd\u30d7\u30ed\u30c6\u30a4\u30f3\uff08a\uff09\u306e\u95a2\u4fc2<\/p>\n<\/section>\n<section>\n<h4>Expert Meeting on Thrombosis\u30002016.7.13\uff08\u795e\u6238\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nSingle Drug Approach: \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>\u7b2c15\u56de\u6176\u61c9\u30fb\u65e5\u533b \u4e0d\u6574\u8108\u30ab\u30f3\u30d5\u30a1\u30e9\u30f3\u30b9\u30002016.7.21(\u6771\u4eac)<\/h4>\n<p>\u91d1\u53e4\u5584\u660e<br \/>\nsuperior slow pathway\u3068\u65b0\u3057\u3044\u623f\u5ba4\u7d50\u7bc0\u30ea\u30a8\u30f3\u30c8\u30ea\u30fc\u6027\u983b\u62cd\u306e\u63d0\u5531\uff0e<\/p>\n<\/section>\n<section>\n<h4>\u7fa4\u99ac\u8102\u80aa\u9178\u30ab\u30f3\u30d5\u30a1\uff5e\u9ad8\u7d14\u5ea6EPA\u3068\u8102\u80aa\u9178\u3092\u3081\u3050\u308b\u30c8\u30d4\u30c3\u30af\u30b9\uff5e\u30002016.7.27\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u78ef\u3000\u9054\u4e5f<br \/>\n\u5fc3\u7b4b\u30a8\u30cd\u30eb\u30ae\u30fc\u57fa\u8cea\u306e\u30b7\u30d5\u30c8\u304c\u5fc3\u6a5f\u80fd\u306b\u53ca\u307c\u3059\u5f71\u97ff\u2015\u8ca0\u8377\u5fc3\u7b4b\u306b\u3068\u3063\u3066\u8102\u80aa\u9178\u3068\u7cd6\u306e\u3069\u3061\u3089\u304c\u6709\u76ca\u304b\u2015<\/p>\n<\/section>\n<section>\n<h4>OSAKA VTE Expert Meeting\u30002016.7.27\uff08\u5927\u962a\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nSingle Drug Approach: \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>4th Clinical Discussion for Heart Failure 2016.7.29(\u524d\u6a4b)<\/h4>\n<p>\uff11\uff09\u98ef\u585a\u8cb4\u58eb<br \/>\n\u80ba\u9ad8\u8840\u5727\u75c7\u306b\u91cd\u5ea6\u4e09\u5c16\u5f01\u9589\u9396\u4e0d\u5168\u75c7\u3092\u5408\u4f75\u3057\u6cbb\u7642\u306b\u96e3\u6e0b\u3057\u305f\uff11\u4f8b<\/p>\n<p>\uff12\uff09\u6751\u7530\u3000\u8aa0<br \/>\nSGLT2\u963b\u5bb3\u85ac\u306fARB\u306e\u6709\u7121\u306b\u304b\u304b\u308f\u3089\u305a\u30ec\u30cb\u30f3\/\u30a2\u30eb\u30c9\u30b9\u30c6\u30ed\u30f3\u6d3b\u6027\u3092\u4f4e\u4e0b\u3055\u305b\u308b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c\uff14\u56de\u7fa4\u99ac\u80ba\u9ad8\u8840\u5727\u75c7\u753b\u50cf\u7814\u7a76\u4f1a\u30002016.8.5\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u9ed2\u6ca2\u5e78\u55e3<br \/>\n\u904b\u52d5\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u30e9\u30a4\u30d6\u30c7\u30e2<\/p>\n<\/section>\n<section>\n<h4>\u5fc3\u81d3\u8840\u7ba1\u30bb\u30f3\u30bf\u30fc\u30bb\u30df\u30ca\u30fc\u30002016.8.5\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u5b89\u9054\u4ec1<br \/>\n\u865a\u8840\u6027\u5fc3\u75be\u60a3\u60a3\u8005\u306b\u304a\u3051\u308b\u6b8b\u4f59\u30ea\u30b9\u30af<\/p>\n<\/section>\n<section>\n<h4>\u7b2c3\u56deiHF\u30d5\u30a9\u30fc\u30e9\u30e0\u30002016.8.6(\u6771\u4eac)<\/h4>\n<p>Iso T,SyamsunarunoMRAA,Yogi Umbarawan,Koitabashi N,Kurabayashi M.<br \/>\nFABP4\/FABP5\u304c\u4e8c\u91cd\u306b\u6b20\u5931\u3059\u308b\u3068\u5727\u8ca0\u8377\u306b\u3088\u308a\u5fc3\u81d3\u306eATP\u751f\u7523\u304c\u8457\u660e\u306b\u4f4e\u4e0b\u3057\u30de\u30a6\u30b9\u5fc3\u6a5f\u80fd\u4f4e\u4e0b\u304c\u5897\u5f37\u3059\u308b<\/p>\n<\/section>\n<section>\n<h4>GUNMA  IPF  ACADEMY\u30002016.8.26(\u524d\u6a4b)<\/h4>\n<p> \u8302\u6728\u3000\u5145<br \/>\n\u7279\u767a\u6027\u80ba\u7dda\u7dad\u75c7\u306e\u8a3a\u65ad\u3000HRCT\u6240\u898b\u306b\u3064\u3044\u3066\u8003\u3048\u308b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c\uff19\u56de\u5927\u5206\u5fc3\u8840\u7ba1\u7814\u7a76\u4f1a\u30002016.9.2\uff08\u5927\u5206\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u7cd6\u5c3f\u75c5\u306e\u5faa\u74b0\u5668\u75be\u60a3\u4e88\u9632\u306f\u65b0\u3057\u3044\u30b9\u30c6\u30fc\u30b8\u3078<\/p>\n<\/section>\n<section>\n<h4>\u7fa4\u99ac\u30ea\u30a6\u30de\u30c1\u30a2\u30ab\u30c7\u30df\u30fc\u30002016.9.2\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<br \/>\n\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u306b\u95a2\u9023\u3059\u308b\u547c\u5438\u5668\u611f\u67d3\u75c7\u306e\u81e8\u5e8a<\/p>\n<\/section>\n<section>\n<h4>\u7b2c50\u56de\u30d8\u30eb\u30b9\u30b1\u30a2\u30bb\u30df\u30ca\u30fc\u30002016.9.26\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u5e83\u4e95\u77e5\u6b73<br \/>\n\u305d\u306e\u75db\u307f\u3001\u5fc3\u81d3\u3067\u3059\u304b\uff1f\uff5e\u5c02\u9580\u533b\u306b\u8a3a\u3066\u3082\u3089\u3046\u3079\u304d\u75c7\u72b6\u3068\u306f\uff5e<\/p>\n<\/section>\n<section>\n<h4>DVT Expert Meeting\u30002016.10.5\uff08\u5175\u5eab\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nSingle Drug Approach: \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>\u30b9\u30c8\u30e9\u30af\u30c1\u30e3\u30fc\u30af\u30e9\u30d6\u30b8\u30e3\u30d1\u30f3\u30fb\u30e9\u30a4\u30d6\u30c7\u30e2\u30f3\u30b9\u30c8\u30ec\u30fc\u30b7\u30e7\u30f32016\u30002016.10.7-8(\u4eac\u90fd) <\/h4>\n<p>\u677e\u5c3e\u5f25\u679d<br \/>\n\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3000\u300c\u5de6\u5fc3\u8033\u9589\u9396\u300d<br \/>\n\u6cbb\u7642\u306e\u5b9f\u969b\uff1a\u4e2d\u9694\u7a7f\u523a\u90e8\u4f4d\u30fb\u30c7\u30d0\u30a4\u30b9\u30b5\u30a4\u30ba\u30fb\u81f3\u9069\u7559\u7f6e\u90e8\u4f4d<\/p>\n<\/section>\n<section>\n<h4>\u7b2c15\u56de\u672a\u75c5\u81e8\u5e8a\u691c\u67fb\u30bb\u30df\u30ca\u30fc\u30002016.10.9(\u524d\u6a4b)<\/h4>\n<p>\u78ef\u3000\u9054\u4e5f<br \/>\n\u4ea4\u611f\u795e\u7d4c\u6d3b\u6027\u5316\u3068\u8840\u4e2dFABP4\u6fc3\u5ea6\u3068\u306e\u95a2\u9023\n <\/p>\n<\/section>\n<section>\n<h4>\u7b2c21\u56de\u5e02\u6c11\u516c\u958b\u8b1b\u5ea7\u30002016.10.10 \uff08\u9ad8\u5d0e)<\/h4>\n<p>\u6e05\u6c34\u96c4\u81f3\u3000<br \/>\n\u5f53\u9662\u306e\u901a\u9662\u6cbb\u7642\u30bb\u30f3\u30bf\u30fc\u306e\u7d39\u4ecb\u3068\u80ba\u304c\u3093\u306e\u85ac\u7269\u7642\u6cd5\u306b\u3064\u3044\u3066\u3002<\/p>\n<\/section>\n<section>\n<h4>\u7b2c230\u56de\u4e00\u822c\u5b9a\u671f\u5065\u5eb7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u80f8\u90e8\u30ec\u30f3\u30c8\u30b2\u30f3\u5199\u771f\u306e\u8aad\u5f71\u8b1b\u5ea7\u30002016.10.17\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<\/p>\n<\/section>\n<section>\n<h4>\u4f50\u91ce\u5e02\u533b\u5e2b\u4f1a\u5171\u50ac\u5b66\u8853\u8b1b\u6f14\u4f1a\u30002016.10.24\uff08\u6803\u6728\u30fb\u4f50\u91ce\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\n\u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>\u7b2c7\u56de\u900f\u6790\u60a3\u8005\u306e\u5faa\u74b0\u5668\u75be\u60a3\u3092\u8003\u3048\u308b\u4f1a\u30002016.10.27(\u524d\u6a4b)<\/h4>\n<p>1)\t\u9577\u8c37\u5ddd\u3000\u662d<br \/>\n\u81e8\u5e8a\u75c7\u72b6\u3001\u5fc3\u96fb\u56f3\u304b\u3089\u306e\u865a\u8840\u6027\u5fc3\u75be\u60a3\u306e\u8a3a\u65ad<\/p>\n<p>2)\t\u9ed2\u6ca2\u5e78\u55e3<br \/>\n\u5fc3\u30a8\u30b3\u30fc\u56f3\u691c\u67fb\u304b\u3089\u306e\u865a\u8840\u6027\u5fc3\u75be\u60a3\u306e\u8a3a\u65ad<\/p>\n<p>\uff13\uff09\u571f\u5c4b\u5bdb\u5b50<br \/>\n\u900f\u6790\u75c7\u4f8b\u306e\u51a0\u52d5\u8108\u75c5\u5909\u306e\u7279\u5fb4<\/p>\n<\/section>\n<section>\n<h4>\u7b2c\uff19\u56de\u8acf\u8a2a\u5730\u533a\u8840\u6813\u30fb\u585e\u6813\u75c7\u4e88\u9632\u7814\u7a76\u4f1a\u30002016.10.28\uff08\u9577\u91ce\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nSingle Drug Approach: \u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u6700\u65b0\u6cbb\u7642<\/p>\n<\/section>\n<section>\n<h4>INNOVATE\u30d7\u30ed\u30b0\u30e9\u30e02016\u611b\u77e5\u30002016.10.29\uff08\u540d\u53e4\u5c4b\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nPE\/DVT\u6cbb\u7642\u30d1\u30b9\u904b\u7528\u306e\u63d0\u6848<\/p>\n<\/section>\n<section>\n<h4>\u7b2c19\u56de\u7fa4\u99ac\u5fc3\u4e0d\u5168\u7814\u7a76\u4f1a\u30002016.10.31\uff08\u524d\u6a4b)<\/h4>\n<p>1)\u5742\u4e95\u4fca\u82f1<br \/>\n\u80ba\u9ad8\u8840\u5727\u75c7\u306b\u91cd\u5ea6\u4e09\u5c16\u5f01\u9589\u9396\u4e0d\u5168\u75c7\u3092\u5408\u4f75\u3057\u6cbb\u7642\u306b\u96e3\u6e0b\u3057\u305f\uff11\u4f8b<\/p>\n<p>2)\u83c5\u91ce\u5e78\u592a<br \/>\n\u5fc3\u914d\u904b\u52d5\u8ca0\u8377\u8a66\u9a13\uff08CPX\uff09\u306b\u3066\u30a2\u30df\u30aa\u30c0\u30ed\u30f3\u306b\u3088\u308b\u80ba\u969c\u5bb3\u306e\u5f71\u97ff\u304c\u8a55\u4fa1\u3067\u304d\u305f\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c\uff14\u56de\u5343\u8449\u30cf\u30fc\u30c8\u30ea\u30ba\u30e0\u7814\u7a76\u4f1a\u30002016.11.2\uff08\u5343\u8449\uff09<\/h4>\n<p>\u91d1\u53e4\u5584\u660e<br \/>\nsuperior slow pathway\u3068\u65b0\u3057\u3044\u623f\u5ba4\u7d50\u7bc0\u30ea\u30a8\u30f3\u30c8\u30ea\u30fc\u6027\u983b\u62cd\u306e\u63d0\u5531<\/p>\n<\/section>\n<section>\n<h4>\u7b2c9\u56de\u7fa4\u99ac\u80ba\u9ad8\u8840\u5727\u75c7\u7814\u7a76\u4f1a\u30002016.11.4(\u524d\u6a4b)<\/h4>\n<p>\u75c7\u4f8b\u63d0\u793a<br \/>\n\uff11\uff09\u53cd\u753a\u79c0\u7f8e<\/p>\n<p>\uff12\uff09\u9ad8\u677e\u5bdb\u4eba<\/p>\n<\/section>\n<section>\n<h4>\u5e73\u621028\u5e74\u5ea6\u3000\u9ad8\u5d0e\u5e02\u611f\u67d3\u75c7\u5bfe\u7b56\u8b1b\u6f14\u4f1a\u30002016.11.9\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<br \/>\n\u9ad8\u9f62\u8005\u80ba\u708e\u3068\u305d\u306e\u4e88\u9632\n <\/p>\n<\/section>\n<section>\n<h4>\u7b2c\uff16\uff12\u56de\u7fa4\u99ac\u770c\u6838\u533b\u5b66\u7814\u7a76\u4f1a\u30002016.11.12(\u524d\u6a4b)<\/h4>\n<p>\u4f50\u85e4\u4e07\u57fa\u4eba\u3001\u7b20\u9593\u3000\u5468\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u7279\u7570\u306a\u5f62\u614b\u3092\u5448\u3057\u305f\u305f\u3053\u3064\u307c\u5fc3\u7b4b\u75c7\u306e\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u5e73\u621028\u5e74\u5ea6\u3000\u9662\u5185ICT\u8b1b\u6f14\u4f1a\u30002016.11.21\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<br \/>\n\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u5bfe\u7b56<\/p>\n<\/section>\n<section>\n<h4>\u7b2c10\u56de\u5929\u4fdd\u5c71\u30cf\u30fc\u30c8\u30af\u30e9\u30d6\u30002016.11.25\uff08\u5927\u962a\uff09<\/h4>\n<p>\u91d1\u53e4\u5584\u660e<br \/>\nsuperior slow pathway \u3068\u65b0\u3057\u3044\u623f\u5ba4\u7d50\u7bc0\u30ea\u30a8\u30f3\u30c8\u30ea\u30fc\u6027\u983b\u62cd\u306e\u63d0\u5531<\/p>\n<\/section>\n<section>\n<h4>INNOVATE\u30d7\u30ed\u30b0\u30e9\u30e02016\u5ca1\u5c71\u30002016.11.29\uff08\u5ca1\u5c71\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nPE\/DVT\u6cbb\u7642\u30d1\u30b9\u904b\u7528\u306e\u63d0\u6848<\/p>\n<\/section>\n<section>\n<h4>\u7b2c231\u56de\u4e00\u822c\u5b9a\u671f\u5065\u5eb7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u80f8\u90e8\u30ec\u30f3\u30c8\u30b2\u30f3\u5199\u771f\u306e\u8aad\u5f71\u8b1b\u5ea7\u30002016.11.30\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<\/p>\n<\/section>\n<section>\n<h4>\u7b2c5\u56deCirculation Frontier in Gunma\u30002016.12.2\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u53cd\u753a\u79c0\u7f8e<br \/>\n\u598a\u5a20\u3092\u5951\u6a5f\u306b\u767a\u75c7\u3057\u305f\u91cd\u75c7\u80ba\u52d5\u8108\u6027\u80ba\u9ad8\u8840\u5727\u75c7\u306e\u4e8c\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7fa4\u99ac\u5fc3\u81d3\u6838\u533b\u5b66\u8b1b\u6f14\u4f1a\u30002016.12.2\u3000\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u9577\u5742\u5d07\u53f8<br \/>\nFFR\u30fb\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\u304c\u6709\u7528\u3067\u3042\u3063\u305f\u305f\u3053\u3064\u307c\u578b\u5fc3\u7b4b\u75c7\u306e1\u4f8b<\/p>\n<\/section>\n<section>\n<h4>INNOVATE in \u795e\u6238\u30002016.12.3\uff08\u5175\u5eab\u30fb\u795e\u6238\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nPE\/DVT\u6cbb\u7642\u30d1\u30b9\u904b\u7528\u306e\u63d0\u6848<\/p>\n<\/section>\n<section>\n<h4>\u03b21-blocker Innovation Conference in Gunma 2016 2016.12.9\u3000\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u5742\u4e95\u4fca\u82f1<br \/>\n\u91cd\u75c7\u6025\u6027\u51a0\u75c7\u5019\u7fa4\u5f8c\u306e\u591a\u5f62\u6027\u5fc3\u5ba4\u983b\u62cd\u306b\u03b2blocker\u304c\u8457\u52b9\u3057\u305f\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u592a\u7530\u5e02\u5b66\u8853\u8b1b\u6f14\u4f1a\u30002016.12.13\uff08\u592a\u7530\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\n\u62e1\u5f35\u4e0d\u5168\u6642\u4ee3\u306e\u964d\u5727\uff5e\u5fc3\u5ba4\u8840\u7ba1\u9023\u95a2\uff5e<\/p>\n<\/section>\n<section>\n<h4>\u6297\u51dd\u56fa\u7642\u6cd5\u30bb\u30df\u30ca\u30fc in Kagoshima\u30002016.12.14\uff08\u9e7f\u5150\u5cf6\uff09<\/h4>\n<p>\u677e\u5c3e\u5f25\u679d<br \/>\n\u5de6\u5fc3\u8033\u9589\u9396\u30c7\u30d0\u30a4\u30b9\u3068\u6297\u51dd\u56fa\u7642\u6cd5\u306e\u4f7f\u3044\u65b9<\/p>\n<\/section>\n<section>\n<h4>\u7b2c188\u56de\u5e02\u6c11\u5065\u5eb7\u533b\u5b66\u8b1b\u5ea7\u30002016.12.21\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<br \/>\nCOPD\uff08\u6162\u6027\u9589\u585e\u6027\u80ba\u75be\u60a3\uff09\u306e\u8a71<\/p>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>\u7b2c28\u56de\u3000\u81e8\u5e8a\u4e0d\u6574\u8108\u7814\u7a76\u4f1a\u30002016.1.9\uff08\u6771\u4eac\uff09 \u98ef\u585a\u8cb4\u58eb\u3001\u98ef\u5cf6\u8cb4\u53f2\u3001\u592a\u7530\u660c\u6a39\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u91d1\u53e4\u5584\u660e\u3001\u5009\u6797\u6b63\u5f66 \u5fc3\u5ba4\u7d30\u52d5\u8607\u751f\u5f8c\u306eBrugada\u75c7\u5019\u7fa4\u306b\u51a0\u6523\u7e2e\u6027\u72ed\u5fc3\u75c7\u306e\u4f75\u767a\u304c\u7591\u308f\u308c\u305f1\u4f8b\uff0e \u5faa\u74b0\u5668\u8a3a\u7642\u304b\u3089\u307f\u305f\u7cd6\u5c3f\u75c5\u6cbb\u7642\u3092 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":199,"menu_order":65,"comment_status":"closed","ping_status":"closed","template":"tpl_results.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-205","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=205"}],"version-history":[{"count":1,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/205\/revisions"}],"predecessor-version":[{"id":206,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/205\/revisions\/206"}],"up":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/199"}],"wp:attachment":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}